Showing 1 - 4 of 4
Persistent link: https://www.econbiz.de/10010360821
In 2009, the National Institute for Health and Clinical Excellence (NICE) issued supplementary advice to its Appraisal Committees to be taken into account when appraising life-extending, ‘end-of-life’ treatments. This indicated that if certain criteria are met, it may be appropriate to...
Persistent link: https://www.econbiz.de/10010793962
A source of debate in the field of health care priority setting is whether health gains should be weighted differently for different groups of patients. The debate has recently focused on the relative value of life extensions for patients with short life expectancy. However, few studies have...
Persistent link: https://www.econbiz.de/10011189654
There is interest in the use of discrete choice experiments that include a duration attribute (DCETTO) to generate health utility values, but questions remain on its feasibility in large health state descriptive systems. This study examines the stability of DCETTO to estimate health utility...
Persistent link: https://www.econbiz.de/10010786442